WO2007064711A2 - Procede et appareil de mesure de la douleur psychologique en tant que moyen de poser un diagnostic, de definir un traitement et de mettre au point un medicament - Google Patents
Procede et appareil de mesure de la douleur psychologique en tant que moyen de poser un diagnostic, de definir un traitement et de mettre au point un medicament Download PDFInfo
- Publication number
- WO2007064711A2 WO2007064711A2 PCT/US2006/045701 US2006045701W WO2007064711A2 WO 2007064711 A2 WO2007064711 A2 WO 2007064711A2 US 2006045701 W US2006045701 W US 2006045701W WO 2007064711 A2 WO2007064711 A2 WO 2007064711A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pain
- psychological
- scale
- psychological pain
- experienced
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4824—Touch or pain perception evaluation
Definitions
- the OMMP scale is not as readily quantifiable as the scale of the instant invention and surveys multiple psychological spheres of the pain experience rather than focusing on measuring psychological pain itself.
- the questions listed in the Orbach scale are less pain specific than those found in the MBS.
- the OMMP has a broad focus, based on nine factors including irreversibility, loss of control, narcissistic wounds, emotional flooding, freezing, self-estrangement, confusion, social distancing, and emptiness.
- the OMMP scale does include two 'pain' questions: "The pain will never go away” and "I will never be able to reduce the pain". However, these questions are categorized under "irreversibility" rather than a direct measure of mental pain.
- Page S psychological pain are interactive complex multidimensional syndromes that have the capacity to influence one another.
- the recognition of psychological pain as a construct could well provide important information concerning the risk for suicide and other outcomes.
- the measurement of psychological pain will further help target novel compounds and/or devices for the treatment of varied pain- related symptoms.
- FiG. 3C is a table listing further brain imaging data of regional activational changes associated with psychological pain paradigms
- Headaches, backaches, abdominal pain, chest pain and facial pain are the most common pain symptoms associated with depression (Creed et al., 1988; Currie & Wang, 2004; Dohrenwend, Raphael, Marbach, & Gallagher, 1999; Lepine & Briley, 2004; Ohayon & Schatzberg, 2003; Schatzberg, 2004; Smith et al M 2004).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
L'invention concerne des procédés et une échelle pouvant fournir une indication multidimensionnelle de la douleur mentale d'une personne, qui présentent de nombreux indicateurs de choix indiquant chacun des variations d'une dimension respective de la douleur mentale. Une échelle de mesure de la douleur psychologique comprend plusieurs éléments d'échelle ayant chacun pour objet de mesurer soit l'intensité de la douleur psychologique, soit la qualité de la douleur psychologique. Le procédé de l'invention consiste à: mettre en oeuvre cette échelle; évaluer le niveau de la douleur mentale d'un patient à l'aide de cette échelle; et exploiter le résultat de cette évaluation pour recommander des régimes thérapeutiques pour le patient. Le procédé de l'invention consiste également à: exploiter ce résultat pour évaluer l'efficacité d'un régime thérapeutique donné sur un patient, ou sur un groupe de patients, tel qu'on en trouve dans des essais cliniques. Enfin, le procédé est conçu pour encourager la mise au point de médicaments destinés à traiter la douleur psychologique et d'autres types de douleur.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74102705P | 2005-11-30 | 2005-11-30 | |
US60/741,027 | 2005-11-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007064711A2 true WO2007064711A2 (fr) | 2007-06-07 |
WO2007064711A3 WO2007064711A3 (fr) | 2009-04-30 |
Family
ID=38092759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/045701 WO2007064711A2 (fr) | 2005-11-30 | 2006-11-29 | Procede et appareil de mesure de la douleur psychologique en tant que moyen de poser un diagnostic, de definir un traitement et de mettre au point un medicament |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007064711A2 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7462155B2 (en) | 2004-10-27 | 2008-12-09 | England Robert L | Objective determination of chronic pain in patients |
CN115860999A (zh) * | 2023-02-27 | 2023-03-28 | 中南大学湘雅医院 | 一种基于物联网老人评估护理系统及方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030059750A1 (en) * | 2000-04-06 | 2003-03-27 | Bindler Paul R. | Automated and intelligent networked-based psychological services |
US20040171056A1 (en) * | 1999-02-22 | 2004-09-02 | Variagenics, Inc., A Delaware Corporation | Gene sequence variations with utility in determining the treatment of disease, in genes relating to drug processing |
US20050113652A1 (en) * | 1999-06-23 | 2005-05-26 | Izex Technologies, Inc. | Remote psychological evaluation |
-
2006
- 2006-11-29 WO PCT/US2006/045701 patent/WO2007064711A2/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040171056A1 (en) * | 1999-02-22 | 2004-09-02 | Variagenics, Inc., A Delaware Corporation | Gene sequence variations with utility in determining the treatment of disease, in genes relating to drug processing |
US20050113652A1 (en) * | 1999-06-23 | 2005-05-26 | Izex Technologies, Inc. | Remote psychological evaluation |
US20030059750A1 (en) * | 2000-04-06 | 2003-03-27 | Bindler Paul R. | Automated and intelligent networked-based psychological services |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7462155B2 (en) | 2004-10-27 | 2008-12-09 | England Robert L | Objective determination of chronic pain in patients |
CN115860999A (zh) * | 2023-02-27 | 2023-03-28 | 中南大学湘雅医院 | 一种基于物联网老人评估护理系统及方法 |
Also Published As
Publication number | Publication date |
---|---|
WO2007064711A3 (fr) | 2009-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sandrini et al. | Abnormal modulatory influence of diffuse noxious inhibitory controls in migraine and chronic tension-type headache patients | |
Moeller-Bertram et al. | Pain and post traumatic stress disorder–review of clinical and experimental evidence | |
Desmeules et al. | Neurophysiologic evidence for a central sensitization in patients with fibromyalgia | |
Staud et al. | Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome | |
Langemark et al. | Pericranial tenderness in tension headache: a blind, controlled study | |
Ashina et al. | Generalized hyperalgesia in patients with chronic tension-type headache | |
Geisser et al. | Comorbid somatic symptoms and functional status in patients with fibromyalgia and chronic fatigue syndrome: sensory amplification as a common mechanism | |
Weisberg | Personality and personality disorders in chronic pain | |
Brosseau et al. | Efficacy of the transcutaneous electrical nerve stimulation for the treatment of chronic low back pain: a meta-analysis | |
Gruener et al. | Differential pain modulation properties in central neuropathic pain after spinal cord injury | |
US7860552B2 (en) | CNS assay for prediction of therapeutic efficacy for neuropathic pain and other functional illnesses | |
Hashmi et al. | Lidocaine patch (5%) is no more potent than placebo in treating chronic back pain when tested in a randomised double blind placebo controlled brain imaging study | |
Kristiansen et al. | The role of pain catastrophizing in experimental pain perception | |
US10881322B2 (en) | Neurophysiological signatures for fibromyalgia | |
Kim et al. | Diminished autonomic neurocardiac function in patients with generalized anxiety disorder | |
Hilton et al. | The effect of pain conditioning on experimentally evoked cough: evidence of impaired endogenous inhibitory control mechanisms in refractory chronic cough | |
US20160048659A1 (en) | Method and tools for predicting a pain response in a subject suffering from cancer-induced bone pain | |
Li et al. | Recognition and treatment of autonomic disturbances in Parkinson’s disease | |
Leone et al. | The CPM effect: functional assessment of the diffuse noxious inhibitory control in humans | |
Cotoi et al. | The effect of theta-burst stimulation on unilateral spatial neglect following stroke: a systematic review | |
Strupf et al. | Cyclic changes in sensations to painful stimuli in migraine patients | |
Revill et al. | Hebbian-type primary motor cortex stimulation: a potential treatment of impaired hand function in chronic stroke patients | |
Barraza-Sandoval et al. | Neurophysiological assessment of painful neuropathies | |
Rosner et al. | Central neuropathic pain | |
Powers et al. | Music to my senses: functional magnetic resonance imaging evidence of music analgesia across connectivity networks spanning the brain and brainstem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06844633 Country of ref document: EP Kind code of ref document: A2 |